# A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer

> **NCT07349043** · PHASE1 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 42 (estimated)

## Conditions studied

- Peritoneal Metastasis
- CRC (Colorectal Cancer)

## Interventions

- **DRUG:** Mitomycin-PIPAC
- **DRUG:** Raltitrexed-PIPAC

## Key facts

- **NCT ID:** NCT07349043
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2027-10
- **Final completion:** 2028-10
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07349043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07349043, "A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer". Retrieved via AI Analytics 2026-07-22 from https://api.ai-analytics.org/clinical/NCT07349043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*